Hospital

The study authors said that further investigation is needed to explore specialized care for mothers and newborns who are affected by hepatitis C infections during pregnancy.

Co-developers Incyte and Syndax will submit a biologics license application to the FDA at the end of 2023 based on the results of a phase 2 trial among adult and pediatric patients with chronic graft-versus-host disease.

Treatment providers have been forced to adapt and make potentially life-altering decisions for patients due to persistent chemotherapy drug shortages, all while solutions from the FDA and drug manufacturers remain scant.

The once-daily therapeutic agent is effective for pediatric patients and pregnant women with HIV.

Pharmacists working with patients with mental health conditions are able to optimize medication use and improve adherence.

Major pharmacogenomics organizations continue to recognize the potential relevance of pharmacogenomics for psychiatric medication management, mainly due to its effects on pharmacokinetics.

Building on promising prior research, ERβ was found to prevent aggressive forms of breast cancer from metastasizing.

The findings showed that interventions to improve sleep could be key to maintaining cognitive function, with investigators calling for further studies.

For adolescents and young adults affected by HIV, Google yielded higher quality information on pre-exposure prophylaxis more frequently compared to other search engines.

Quitting treatment may significantly improve severe hypertension in patients with hepatocellular carcinoma.

Managing cost savings can soften the blow of direct and indirect remuneration fee reform that will impact pharmacists during the first half of 2024.

Christina M. Madison, PharmD, FCCP, AAHIVP, sat down with Lydia Bailey, PharmD, BCACP, pharmacy operations manager at St. Vincent De Paul Charitable Pharmacy

These data support a paradigm shift in the treatment of locally advanced rectal cancer.

Despite the surge in new diabetes cases, the treatment options in in children remain limited.

For many patients with C diff, the experience of medical gaslighting is a common one because many health care providers lack education and familiarity with the disease.

Idiopathic intracranial hypertension was previously considered a rare condition, however, its prevalence is increasing in parallel with obesity in patient populations.

Investigators said pre-exposure prophylaxis rollout is efficient in settings with high HIV incidence, but not in settings with low HIV incidence.

The findings could help in future vaccine prioritization strategies and therapeutic allocation policies for other pandemic.

Specialty pharmacists can have more contact with patients than providers.

Generic ketamine could cost as little as $5, which is significantly lower than the $800 per dose for the currently available S-ketamine nasal spray.

Due to the assessment of computerized tomography with criteria from 1999, the role of radiotherapy in patients with diffuse large B-cell lymphoma with bulky or extranodal disease remains undefined.

Patients with perinatally-acquired HIV reported low emotional, instrumental, and friendship support at 37%, 32%, and 36%, respectively.

The 5-year survival rate for patients with exon 20 insertion EFGR mutation is 8% in the frontline setting, worse than the survival rate of the 2 most common types of EGFR mutations in patients with advanced or metastatic non-small cell lung cancer.

Participants were able to stop treatment after achieving amyloid plaque clearance and experience lasting results.

Therapeutic drug monitoring is a growing and vital area for pharmacists to become involved in to increase patient success with inflammatory bowel disease remission.

Though the overall significance of the results were low, vitamin D was found to be especially useful in lowering the prevalence of myocardial infarction in older adults.

Pharmacist-led discharge stewardship initiatives have shown promising results.

A significant proportion of patients had negative hepatitis B surface antibody titers, indicating a need for vaccination to ensure protection for patients undergoing hemodialysis.

The approval marks the first monoclonal antibody approved to protect all infants through their first respiratory syncytial virus season.

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.